Clinical Trial Update: Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating combination chemotherapy with or without etoposide in older patients with Non-Hodgkin's lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Toposar (Etoposide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma | Phase 2, Phase 3 | Status: TERMINATED